Profile data is unavailable for this security.
About the company
Bioventix plc is a United Kingdom-based biotechnology company. The Company specializes in the development and commercial supply of high-affinity monoclonal antibodies with a primary focus on their application in clinical diagnostics, such as in automated immunoassays used in blood testing. It has created a sheep hybridoma technology to produce stable and productive cell lines that secrete sheep monoclonal antibodies (SMAs) of very high affinity. Its recombinant FAbs are modified to enable simple conjugation to enzymes (HRP, AP) or biotinylation or association as dimeric FAb2. It offers a portfolio of antibodies to customers for both commercial use and research and development purposes for the diagnosis or monitoring of a broad range of conditions, including heart disease, cancer, fertility, thyroid function, and drug abuse. It provides ELISA Kits to monitor human exposure to industrial pollutants. It supplies antibody products and services to clinical diagnostics companies.
- Revenue in GBP (TTM)13.60m
- Net income in GBP8.67m
- Incorporated2003
- Employees16.00
- LocationBioventix PLC7 Romans Business Park, East StreetFARNHAM GU9 7SXUnited KingdomGBR
- Phone+44 125 272 8001
- Fax+44 125 272 8002
- Websitehttps://www.bioventix.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Creo Medical Group PLC | 29.23m | -25.10m | 125.61m | 279.00 | -- | 1.77 | -- | 4.30 | -0.1139 | -0.1139 | 0.126 | 0.1966 | 0.3318 | 1.87 | 4.14 | 102,926.10 | -28.49 | -- | -34.24 | -- | 48.11 | -- | -85.87 | -- | 3.45 | -- | 0.1177 | -- | 7.98 | -- | -9.52 | -- | -- | -- |
| Animalcare Group Plc | 74.35m | 1.20m | 130.43m | 220.00 | 109.76 | 1.67 | 14.80 | 1.75 | 0.0198 | 0.0198 | 1.22 | 1.30 | 0.6608 | 2.63 | 5.54 | -- | 1.07 | 0.3272 | 1.30 | 0.3866 | 58.30 | 53.62 | 1.61 | 0.5484 | 1.05 | 5.44 | 0.0701 | 599.95 | 3.82 | 0.5138 | -38.98 | -- | -11.79 | 2.59 |
| Allergy Therapeutics plc | 53.26m | -50.22m | 133.46m | 635.00 | -- | 5.04 | -- | 2.51 | -0.0266 | -0.0266 | 0.017 | 0.0056 | 0.7571 | 2.21 | 4.92 | 83,870.87 | -71.39 | -11.59 | -102.10 | -15.15 | 52.54 | 70.08 | -94.29 | -11.78 | 0.9281 | -7.93 | 0.2713 | -- | -18.11 | -2.71 | -212.65 | -- | 16.41 | -- |
| 4Basebio PLC | 354.00k | -6.28m | 133.81m | -- | -- | 37.74 | -- | 378.01 | -0.5094 | -0.5094 | 0.0287 | 0.2769 | 0.0296 | 0.3977 | 4.88 | -- | -52.42 | -- | -60.21 | -- | 80.51 | -- | -1,772.60 | -- | 3.28 | -40.29 | 0.6683 | -- | -20.71 | -- | -59.20 | -- | -- | -- |
| Avacta Group Plc | 16.03m | -42.08m | 159.77m | 120.00 | -- | 5.39 | -- | 9.97 | -0.1605 | -0.1633 | 0.0606 | 0.0826 | 0.2406 | 4.50 | 2.38 | 133,541.70 | -63.18 | -- | -119.23 | -- | 54.40 | -- | -262.60 | -- | 0.6603 | -1.66 | 0.6913 | -- | 228.22 | -- | -49.92 | -- | -- | -- |
| Alliance Pharma plc | 170.05m | -7.06m | 191.84m | 249.00 | -- | 0.6924 | 61.25 | 1.13 | -0.0131 | -0.0131 | 0.3145 | 0.5127 | 0.3202 | 2.88 | 4.40 | 682,927.70 | -1.33 | 2.64 | -1.47 | 2.95 | 57.58 | 63.38 | -4.15 | 8.35 | 1.38 | 2.18 | 0.31 | 53.41 | 2.58 | 10.50 | -87.21 | -49.62 | -25.78 | 5.94 |
| hVIVO PLC | 56.04m | 16.12m | 192.21m | 274.00 | 12.08 | 5.60 | 10.21 | 3.43 | 0.0234 | 0.0234 | 0.0817 | 0.0505 | 0.8327 | -- | 4.08 | 204,536.50 | 23.94 | -0.643 | 46.27 | -1.29 | -- | -- | 28.75 | -0.765 | 1.47 | -- | 0.2674 | -- | 15.61 | 35.40 | 2,176.68 | -- | 136.55 | -- |
| Oxford BioMedica plc | 119.02m | -61.63m | 215.00m | 891.00 | -- | 1.21 | -- | 1.81 | -0.6389 | -0.6389 | 1.23 | 1.78 | 0.2743 | 4.67 | 3.09 | 131,662.60 | -16.18 | -4.45 | -21.95 | -5.69 | 46.20 | 53.90 | -58.97 | -8.16 | 3.07 | -9.24 | 0.3635 | -- | -1.97 | 30.08 | -305.97 | -- | 52.60 | -- |
| Bioventix PLC | 13.60m | 8.67m | 233.58m | 16.00 | 27.41 | 20.43 | 26.58 | 17.18 | 1.63 | 1.63 | 2.56 | 2.19 | 1.09 | 1.53 | 2.54 | 849,780.60 | 69.72 | 56.43 | 79.03 | 61.01 | 93.75 | 92.64 | 63.73 | 65.08 | 6.69 | -- | 0.00 | 84.49 | 9.36 | 7.93 | 9.10 | 8.13 | -37.12 | 20.03 |
| Niox Group PLC | 36.80m | 9.50m | 282.39m | 85.00 | 31.60 | 3.13 | 20.32 | 7.67 | 0.0211 | 0.0238 | 0.0819 | 0.2136 | 0.3874 | 2.31 | 6.13 | 432,941.20 | 10.00 | -2.41 | 10.57 | -2.90 | 72.01 | 70.87 | 25.82 | -11.46 | 3.99 | -- | 0.013 | -- | 17.57 | -5.29 | -32.62 | -- | -5.59 | -- |
| Holder | Shares | % Held |
|---|---|---|
| Sanford DeLand Asset Management Ltd.as of 10 Apr 2024 | 619.50k | 11.87% |
| Liontrust Investment Partners LLPas of 27 Oct 2023 | 574.16k | 11.00% |
| Link Fund Solutions Ltd.as of 29 Dec 2023 | 363.63k | 6.97% |
| Gresham House Asset Management Ltd. (Investment Management)as of 01 Sep 2023 | 289.00k | 5.54% |
| Rathbones Investment Management Ltd.as of 27 Oct 2023 | 164.94k | 3.16% |
| Investec Wealth & Investment Ltd.as of 01 Sep 2023 | 145.00k | 2.78% |
| Joh. Berenberg, Gossler & Co. KG (Investment Management)as of 30 Dec 2022 | 131.03k | 2.51% |
| Hargreaves Lansdown Asset Management Ltd.as of 01 Sep 2023 | 114.00k | 2.18% |
| EdenTree Investment Management Ltd.as of 01 Sep 2023 | 100.00k | 1.92% |
| Walker Crips Investment Management Ltd.as of 01 Sep 2023 | 70.00k | 1.34% |
